Revvity Inc. (NYSE:RVTY) Receives Average Recommendation of "Moderate Buy" from Brokerages

Key Points

• Revvity Inc. has received an average analyst recommendation of "Moderate Buy," with ten analysts recommending a buy and four recommending a hold. The average 1-year price target is $120.07.
• The company reported $1.18 EPS in its last quarterly earnings, surpassing the consensus estimate of $1.14, and had revenues of $720.28 million, an increase of 4.1% year-over-year.
• Revvity has announced a quarterly dividend of $0.07 per share, providing a yield of 0.3%, with the payment set for November 7th to shareholders of record on October 17th.

Shares of Revvity Inc. (NYSE:RVTY - Get Free Report) have received a consensus rating of "Moderate Buy" from the fourteen brokerages that are covering the firm, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average 12 month price target among brokerages that have covered the stock in the last year is $119.2857.

A number of research analysts recently issued reports on the stock. Raymond James Financial reiterated an "outperform" rating and set a $115.00 target price (down previously from $120.00) on shares of Revvity in a research report on Tuesday, July 29th. Stifel Nicolaus dropped their target price on shares of Revvity from $120.00 to $110.00 and set a "hold" rating on the stock in a research report on Tuesday, July 29th. Evercore ISI dropped their target price on shares of Revvity from $116.00 to $115.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 8th. Wall Street Zen downgraded shares of Revvity from a "buy" rating to a "hold" rating in a report on Sunday, August 3rd. Finally, Bank of America lowered their price objective on shares of Revvity from $110.00 to $99.00 and set a "buy" rating on the stock in a report on Monday.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of RVTY. Price T Rowe Associates Inc. MD raised its holdings in Revvity by 25.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 9,563,911 shares of the company's stock worth $1,011,863,000 after buying an additional 1,932,314 shares during the last quarter. T. Rowe Price Investment Management Inc. grew its stake in shares of Revvity by 8.5% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 22,515,711 shares of the company's stock worth $2,382,163,000 after acquiring an additional 1,754,403 shares in the last quarter. EdgePoint Investment Group Inc. grew its stake in shares of Revvity by 26.7% in the 2nd quarter. EdgePoint Investment Group Inc. now owns 6,789,660 shares of the company's stock worth $656,696,000 after acquiring an additional 1,428,813 shares in the last quarter. Norges Bank bought a new stake in shares of Revvity in the 2nd quarter worth $124,574,000. Finally, Invesco Ltd. grew its stake in shares of Revvity by 25.8% in the 2nd quarter. Invesco Ltd. now owns 2,207,202 shares of the company's stock worth $213,481,000 after acquiring an additional 452,343 shares in the last quarter. Institutional investors and hedge funds own 86.65% of the company's stock.

Revvity Stock Down 0.4%

Shares of Revvity stock traded down $0.34 during trading on Monday, reaching $86.38. 1,034,461 shares of the company traded hands, compared to its average volume of 1,316,452. The company has a debt-to-equity ratio of 0.43, a current ratio of 3.33 and a quick ratio of 2.75. Revvity has a 1-year low of $81.36 and a 1-year high of $129.50. The company has a 50 day moving average price of $89.79 and a 200-day moving average price of $94.85. The firm has a market capitalization of $10.03 billion, a PE ratio of 17.73, a P/E/G ratio of 2.33 and a beta of 0.94.

Revvity (NYSE:RVTY - Get Free Report) last released its earnings results on Monday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.14 by $0.04. Revvity had a net margin of 10.19% and a return on equity of 7.66%. The company had revenue of $720.28 million for the quarter, compared to the consensus estimate of $711.26 million. During the same quarter in the previous year, the company earned $1.22 EPS. Revvity's quarterly revenue was up 4.1% compared to the same quarter last year. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. As a group, equities research analysts expect that Revvity will post 4.94 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 7th. Shareholders of record on Friday, October 17th will be issued a dividend of $0.07 per share. The ex-dividend date is Friday, October 17th. This represents a $0.28 annualized dividend and a yield of 0.3%. Revvity's dividend payout ratio is presently 11.86%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.